Arteris (NASDAQ:AIP) Upgraded by Wall Street Zen to Hold Rating

Key Points

• Arteris was upgraded from a "sell" to a "hold" rating by Wall Street Zen, while three analysts maintain a "buy" rating with an average target price of $15.00.
• The company reported quarterly earnings that met expectations, with revenue of $16.50 million, higher than analysts' expectations of $16.35 million.
• Insiders sold a total of 456,043 shares of Arteris stock over the last three months, and institutional investors currently own 64.36% of the company's shares.

Wall Street Zen upgraded shares of Arteris (NASDAQ:AIP - Free Report) from a sell rating to a hold rating in a research note published on Saturday morning.

A number of other equities research analysts also recently weighed in on AIP. Rosenblatt Securities restated a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st. TD Cowen boosted their target price on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $15.00.

Arteris Price Performance

Shares of AIP stock traded down $0.20 on Friday, reaching $8.86. 265,344 shares of the stock were exchanged, compared to its average volume of 546,316. The stock has a market cap of $377.67 million, a PE ratio of -10.80 and a beta of 1.44. Arteris has a one year low of $5.46 and a one year high of $14.29. The stock has a 50 day moving average price of $9.57 and a 200 day moving average price of $8.25.

Arteris (NASDAQ:AIP - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.11). The company had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts expect that Arteris will post -0.73 earnings per share for the current fiscal year.

Insider Transactions at Arteris

In other Arteris news, Director Saiyed Atiq Raza sold 63,118 shares of the business's stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.07, for a total value of $824,952.26. Following the completion of the transaction, the director directly owned 590,000 shares of the company's stock, valued at approximately $7,711,300. The trade was a 9.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO K Charles Janac sold 94,245 shares of the business's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.49, for a total value of $1,271,365.05. Following the completion of the transaction, the chief executive officer directly owned 189,785 shares of the company's stock, valued at approximately $2,560,199.65. The trade was a 33.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 449,499 shares of company stock valued at $5,432,766. Insiders own 33.70% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. acquired a new position in Arteris in the first quarter valued at about $95,000. G2 Investment Partners Management LLC acquired a new position in shares of Arteris during the fourth quarter worth about $2,799,000. BNP Paribas Financial Markets acquired a new position in shares of Arteris during the fourth quarter worth about $214,000. Two Sigma Advisers LP boosted its position in shares of Arteris by 82.9% during the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock worth $240,000 after buying an additional 10,700 shares during the period. Finally, Price T Rowe Associates Inc. MD acquired a new position in shares of Arteris during the fourth quarter worth about $117,000. 64.36% of the stock is owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.